Concepedia

Publication | Open Access

Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid

DOIFull Paper Access

13

Citations

16

References

2017

Year

Masashi Yanae, Shinichiro Fujimoto, Kaori Tane, Maki Tanioka, Kimiko Fujiwara, Masanobu Tsubaki, Yuzuru Yamazoe, Y Morishima, Yasutaka Chiba, Shintaro Takao,
Journal of bone oncology

Abstract

Bone-only MBC patients are more likely to experience an SSE even after treatment with ZA.

References

YearCitations

Page 1